Tang Capital Management
Latest statistics and disclosures from Tang Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are EOLS, TARS, AUPH, VRDN, MIRM, and represent 21.92% of Tang Capital Management's stock portfolio.
- Added to shares of these 10 stocks: AUPH (+$33M), BNTX (+$32M), RLAY (+$25M), ITOS (+$25M), IMCR (+$22M), VRDN (+$19M), GLPG (+$19M), NBIX (+$17M), NVAX (+$13M), CRBP (+$12M).
- Started 35 new stock positions in AFMD, BLCO, NVAX, HLVX, RLAY, NBIX, ELAN, ALLK, NUVL, SHW.
- Reduced shares in these 10 stocks: LLY (-$24M), DVAX (-$6.7M), Mirum Pharmaceuticals Inc Note 4.000 5/0, BEAM, INBX, CRSP, , MCRB, ENTA, ADAP.
- Sold out of its positions in ADAP, ALGS, QNCX, DEI, INBX, DERM, LLY, Mirum Pharmaceuticals Inc Note 4.000 5/0, MOLN.
- Tang Capital Management was a net buyer of stock by $310M.
- Tang Capital Management has $1.4B in assets under management (AUM), dropping by 42.57%.
- Central Index Key (CIK): 0001232621
Tip: Access up to 7 years of quarterly data
Positions held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 154 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Evolus (EOLS) | 5.6 | $79M | 4.8M | 16.20 |
|
|
| Tarsus Pharmaceuticals (TARS) | 5.3 | $74M | 2.3M | 32.89 |
|
|
| Aurinia Pharmaceuticals (AUPH) | 3.8 | $53M | +160% | 7.2M | 7.33 |
|
| Miragen Therapeutics (VRDN) | 3.6 | $51M | +61% | 2.2M | 22.75 |
|
| Mirum Pharmaceuticals (MIRM) | 3.6 | $50M | 1.3M | 39.00 |
|
|
| Kalvista Pharmaceuticals (KALV) | 3.6 | $50M | +2% | 4.3M | 11.58 |
|
| Anaptysbio Inc Common (ANAB) | 3.2 | $45M | 1.3M | 33.50 |
|
|
| Immunocore Hldgs Ads (IMCR) | 2.5 | $34M | +172% | 1.1M | 31.13 |
|
| Vaxcyte (PCVX) | 2.4 | $34M | 300k | 114.27 |
|
|
| Biontech Se Sponsored Ads (BNTX) | 2.3 | $32M | NEW | 270k | 118.77 |
|
| Biosante Pharmaceuticals (ANIP) | 1.9 | $27M | 450k | 59.66 |
|
|
| Ptc Therapeutics I (PTCT) | 1.9 | $26M | 700k | 37.10 |
|
|
| Relay Therapeutics (RLAY) | 1.8 | $25M | NEW | 3.6M | 7.08 |
|
| Iteos Therapeutics (ITOS) | 1.8 | $25M | NEW | 2.4M | 10.21 |
|
| Applied Therapeutics (APLT) | 1.7 | $23M | +17% | 2.7M | 8.50 |
|
| ACADIA Pharmaceuticals (ACAD) | 1.6 | $23M | 1.5M | 15.38 |
|
|
| Intra Cellular Therapies (ITCI) | 1.6 | $22M | 300k | 73.17 |
|
|
| Dynavax Technologies Corp Com New (DVAX) | 1.5 | $21M | -24% | 1.9M | 11.14 |
|
| Galapagos Nv Spon Adr (GLPG) | 1.4 | $20M | +1158% | 700k | 28.79 |
|
| GSK Sponsored Adr (GSK) | 1.3 | $18M | +12% | 450k | 40.88 |
|
| Lenz Therapeutics (LENZ) | 1.3 | $18M | +2% | 767k | 23.74 |
|
| NVIDIA Corporation (NVDA) | 1.3 | $18M | +28% | 148k | 121.44 |
|
| Neurocrine Biosciences (NBIX) | 1.2 | $17M | NEW | 150k | 115.22 |
|
| Altimmune Com New (ALT) | 1.2 | $17M | 2.8M | 6.14 |
|
|
| Avadel Pharmaceuticals Com Shs (AVDL) | 1.2 | $16M | 1.2M | 13.12 |
|
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.1 | $16M | 629k | 24.99 |
|
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.1 | $16M | 140k | 111.41 |
|
|
| Atea Pharmaceuticals (AVIR) | 1.1 | $15M | +2% | 4.6M | 3.35 |
|
| Cullinan Oncology (CGEM) | 1.1 | $15M | 921k | 16.74 |
|
|
| Meta Platforms Cl A (META) | 1.1 | $15M | +126% | 26k | 572.45 |
|
| Rocket Pharmaceuticals (RCKT) | 1.0 | $14M | 750k | 18.47 |
|
|
| Zymeworks Del (ZYME) | 1.0 | $14M | 1.1M | 12.55 |
|
|
| Replimune Group (REPL) | 0.9 | $13M | +48% | 1.2M | 10.96 |
|
| Revance Therapeutics (RVNC) | 0.9 | $13M | +525% | 2.5M | 5.19 |
|
| Cargo Therapeutics (CRGX) | 0.9 | $13M | +22% | 701k | 18.45 |
|
| Teladoc (TDOC) | 0.9 | $13M | +40% | 1.4M | 9.18 |
|
| Novavax Com New (NVAX) | 0.9 | $13M | NEW | 1.0M | 12.63 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.9 | $13M | -15% | 267k | 46.98 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.9 | $12M | NEW | 600k | 20.63 |
|
| Adicet Bio (ACET) | 0.8 | $12M | 8.2M | 1.44 |
|
|
| Astrazeneca Sponsored Adr (AZN) | 0.8 | $12M | 150k | 77.91 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 0.8 | $11M | 281k | 40.00 |
|
|
| Vanda Pharmaceuticals (VNDA) | 0.8 | $11M | +9% | 2.4M | 4.69 |
|
| Immunome (IMNM) | 0.8 | $11M | 720k | 14.62 |
|
|
| Cytomx Therapeutics (CTMX) | 0.7 | $9.2M | 7.8M | 1.18 |
|
|
| Nuvation Bio Com Cl A (NUVB) | 0.6 | $8.9M | +3% | 3.9M | 2.29 |
|
| Elanco Animal Health (ELAN) | 0.6 | $8.8M | NEW | 600k | 14.69 |
|
| Hillevax (HLVX) | 0.6 | $8.7M | NEW | 4.9M | 1.76 |
|
| Outlook Therapeutics (OTLK) | 0.6 | $8.3M | -3% | 1.6M | 5.34 |
|
| Beigene Sponsored Adr (BGNE) | 0.6 | $8.3M | 37k | 224.51 |
|
|
| Marinus Pharmaceuticals Com New (MRNS) | 0.6 | $8.3M | -2% | 4.7M | 1.76 |
|
| Liquidia Corporation Com New (LQDA) | 0.6 | $8.0M | +128% | 800k | 10.00 |
|
| Design Therapeutics (DSGN) | 0.6 | $8.0M | 1.5M | 5.38 |
|
|
| Alx Oncology Hldgs (ALXO) | 0.5 | $7.7M | NEW | 4.2M | 1.82 |
|
| Viking Therapeutics (VKTX) | 0.5 | $7.6M | 120k | 63.31 |
|
|
| Insmed Com Par $.01 (INSM) | 0.5 | $7.3M | 100k | 73.00 |
|
|
| Dianthus Therapeutics (DNTH) | 0.5 | $7.2M | 265k | 27.38 |
|
|
| Biohaven (BHVN) | 0.5 | $7.0M | 140k | 49.97 |
|
|
| Biogen Idec (BIIB) | 0.5 | $6.8M | 35k | 193.84 |
|
|
| Ventyx Biosciences (VTYX) | 0.5 | $6.8M | 3.1M | 2.18 |
|
|
| Bausch Plus Lomb Corp Common Shares (BLCO) | 0.5 | $6.8M | NEW | 350k | 19.29 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $6.4M | NEW | 400k | 15.99 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $6.3M | 145k | 43.89 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $6.1M | 800k | 7.60 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.4 | $6.0M | 150k | 40.06 |
|
|
| Abcellera Biologics (ABCL) | 0.4 | $6.0M | +398% | 2.3M | 2.60 |
|
| Black Diamond Therapeutics (BDTX) | 0.4 | $6.0M | -14% | 1.4M | 4.35 |
|
| Apogee Therapeutics (APGE) | 0.4 | $5.9M | 100k | 58.74 |
|
|
| Singular Genomics Systems In Com New (OMIC) | 0.4 | $5.8M | NEW | 372k | 15.67 |
|
| Precision Biosciences Com New (DTIL) | 0.4 | $5.6M | 623k | 8.96 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.4 | $5.5M | 50k | 109.75 |
|
|
| Cytokinetics Com New (CYTK) | 0.4 | $5.3M | 100k | 52.80 |
|
|
| Nuvalent Inc-a (NUVL) | 0.4 | $5.1M | NEW | 50k | 102.30 |
|
| Reneo Pharmaceuticals (RPHM) | 0.4 | $5.0M | 2.9M | 1.70 |
|
|
| Merus N V (MRUS) | 0.4 | $5.0M | 100k | 49.96 |
|
|
| Alexandria Real Estate Equities (ARE) | 0.3 | $4.8M | 40k | 118.75 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.3 | $4.7M | 500k | 9.39 |
|
|
| Alumis (ALMS) | 0.3 | $4.6M | NEW | 427k | 10.68 |
|
| Seer Com Cl A (SEER) | 0.3 | $4.5M | 2.3M | 1.97 |
|
|
| Arvinas Ord (ARVN) | 0.3 | $4.4M | 180k | 24.63 |
|
|
| Beam Therapeutics (BEAM) | 0.3 | $4.2M | -37% | 170k | 24.50 |
|
| Sanofi Sponsored Adr (SNY) | 0.3 | $4.0M | NEW | 70k | 57.63 |
|
| C4 Therapeutics Com Stk (CCCC) | 0.3 | $4.0M | +250% | 700k | 5.70 |
|
| Heron Therapeutics (HRTX) | 0.3 | $3.7M | 1.9M | 1.99 |
|
|
| Cybin Com New | 0.3 | $3.6M | NEW | 400k | 8.89 |
|
| Tyra Biosciences (TYRA) | 0.3 | $3.5M | +255% | 150k | 23.51 |
|
| Compass Therapeutics (CMPX) | 0.2 | $3.3M | NEW | 1.8M | 1.84 |
|
| Nkarta (NKTX) | 0.2 | $2.9M | +18% | 650k | 4.52 |
|
| Elevation Oncology (ELEV) | 0.2 | $2.9M | +55% | 4.8M | 0.60 |
|
| Kezar Life Sciences (KZR) | 0.2 | $2.8M | NEW | 3.6M | 0.77 |
|
| Bolt Biotherapeutics (BOLT) | 0.2 | $2.5M | 3.8M | 0.65 |
|
|
| Fate Therapeutics (FATE) | 0.2 | $2.5M | 700k | 3.50 |
|
|
| Coherus Biosciences (CHRS) | 0.2 | $2.4M | +123% | 2.4M | 1.04 |
|
| Genmab A/s Sponsored Ads (GMAB) | 0.2 | $2.4M | 100k | 24.38 |
|
|
| Tectonic Therapeutic (TECX) | 0.2 | $2.4M | 79k | 30.30 |
|
|
| Springworks Therapeutics (SWTX) | 0.2 | $2.4M | NEW | 74k | 32.04 |
|
| Tg Therapeutics (TGTX) | 0.2 | $2.3M | 100k | 23.39 |
|
|
| Theravance Biopharma (TBPH) | 0.2 | $2.1M | NEW | 263k | 8.06 |
|
| Kura Oncology (KURA) | 0.1 | $2.0M | 100k | 19.54 |
|
|
| Century Therapeutics (IPSC) | 0.1 | $1.5M | 900k | 1.71 |
|
|
| Bioatla (BCAB) | 0.1 | $1.5M | -36% | 874k | 1.76 |
|
| Erasca (ERAS) | 0.1 | $1.4M | -8% | 503k | 2.73 |
|
| Enanta Pharmaceuticals (ENTA) | 0.1 | $1.3M | -57% | 127k | 10.36 |
|
| Omniab (OABI) | 0.1 | $1.3M | 300k | 4.23 |
|
|
| Atyr Pharma Com New (ATYR) | 0.1 | $1.2M | 671k | 1.76 |
|
|
| Astria Therapeutics (ATXS) | 0.1 | $1.1M | 100k | 11.01 |
|
|
| Passage Bio (PASG) | 0.1 | $1.1M | 1.5M | 0.70 |
|
|
| Wal-Mart Stores (WMT) | 0.1 | $1.0M | +185% | 13k | 80.75 |
|
| JPMorgan Chase & Co. (JPM) | 0.1 | $985k | +158% | 4.7k | 210.85 |
|
| Microsoft Corporation (MSFT) | 0.1 | $968k | +176% | 2.3k | 430.30 |
|
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 0.1 | $957k | +192% | 2.1k | 460.26 |
|
| Home Depot (HD) | 0.1 | $954k | +246% | 2.4k | 405.26 |
|
| Pacira Pharmaceuticals (PCRX) | 0.1 | $922k | NEW | 61k | 15.05 |
|
| Verizon Communications (VZ) | 0.1 | $916k | +284% | 20k | 44.91 |
|
| Visa Com Cl A (V) | 0.1 | $912k | +216% | 3.3k | 274.92 |
|
| Nextcure (NXTC) | 0.1 | $894k | +8% | 652k | 1.37 |
|
| Procter & Gamble Company (PG) | 0.1 | $891k | +233% | 5.1k | 173.21 |
|
| Coca-Cola Company (KO) | 0.1 | $889k | +247% | 12k | 71.86 |
|
| Texas Instruments Incorporated (TXN) | 0.1 | $868k | +249% | 4.2k | 206.56 |
|
| Paypal Holdings (PYPL) | 0.1 | $866k | NEW | 11k | 78.03 |
|
| Intel Corporation (INTC) | 0.1 | $858k | +397% | 37k | 23.46 |
|
| Viatris (VTRS) | 0.1 | $858k | +234% | 74k | 11.61 |
|
| Walt Disney Company (DIS) | 0.1 | $850k | +335% | 8.8k | 96.19 |
|
| Nike CL B (NKE) | 0.1 | $843k | NEW | 9.5k | 88.40 |
|
| UnitedHealth (UNH) | 0.1 | $831k | NEW | 1.4k | 584.64 |
|
| Exxon Mobil Corporation (XOM) | 0.1 | $821k | +267% | 7.0k | 117.21 |
|
| Johnson & Johnson (JNJ) | 0.1 | $813k | NEW | 5.0k | 162.05 |
|
| Verastem Com New (VSTM) | 0.1 | $807k | -50% | 270k | 2.99 |
|
| D Fluidigm Corp Del (LAB) | 0.1 | $787k | NEW | 408k | 1.93 |
|
| Pfizer (PFE) | 0.1 | $745k | NEW | 26k | 28.94 |
|
| Macrogenics (MGNX) | 0.1 | $720k | 219k | 3.29 |
|
|
| Atara Biotherapeutics Com New (ATRA) | 0.0 | $611k | 75k | 8.13 |
|
|
| Puma Biotechnology (PBYI) | 0.0 | $510k | 200k | 2.55 |
|
|
| Affimed N V Ordinary Shs New (AFMD) | 0.0 | $498k | NEW | 148k | 3.36 |
|
| Precigen (PGEN) | 0.0 | $474k | NEW | 500k | 0.95 |
|
| Eagle Pharmaceuticals (EGRX) | 0.0 | $443k | 119k | 3.73 |
|
|
| Adagio Therapeutics (IVVD) | 0.0 | $337k | +65% | 330k | 1.02 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.0 | $324k | 100k | 3.24 |
|
|
| Netflix (NFLX) | 0.0 | $303k | 427.00 | 709.28 |
|
|
| American Express Company (AXP) | 0.0 | $271k | 1.0k | 271.07 |
|
|
| Athira Pharma (ATHA) | 0.0 | $268k | -43% | 600k | 0.45 |
|
| Ge Aerospace Com New (GE) | 0.0 | $261k | 1.4k | 188.57 |
|
|
| Allstate Corporation (ALL) | 0.0 | $239k | 1.3k | 189.70 |
|
|
| Sherwin-Williams Company (SHW) | 0.0 | $234k | NEW | 612.00 | 381.76 |
|
| Metropcs Communications (TMUS) | 0.0 | $221k | NEW | 1.1k | 206.41 |
|
| Hldgs (UAL) | 0.0 | $221k | NEW | 3.9k | 57.06 |
|
| Amazon (AMZN) | 0.0 | $217k | 1.2k | 186.29 |
|
|
| Clorox Company (CLX) | 0.0 | $201k | NEW | 1.2k | 162.96 |
|
| Seres Therapeutics (MCRB) | 0.0 | $189k | -91% | 200k | 0.95 |
|
| Relmada Therapeutics (RLMD) | 0.0 | $165k | -78% | 51k | 3.24 |
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.0 | $157k | NEW | 100k | 1.57 |
|
| Ford Motor Company (F) | 0.0 | $135k | 13k | 10.56 |
|
|
| Lava Therapeutics Nv SHS (LVTX) | 0.0 | $88k | +939% | 53k | 1.66 |
|
| Allakos (ALLK) | 0.0 | $30k | NEW | 45k | 0.65 |
|
Past Filings by Tang Capital Management
SEC 13F filings are viewable for Tang Capital Management going back to 2011
- Tang Capital Management 2024 Q3 filed Nov. 14, 2024
- Tang Capital Management 2024 Q2 filed Aug. 14, 2024
- Tang Capital Management 2024 Q1 filed May 15, 2024
- Tang Capital Management 2023 Q4 filed Feb. 14, 2024
- Tang Capital Management 2023 Q3 filed Nov. 14, 2023
- Tang Capital Management 2023 Q2 filed Aug. 14, 2023
- Tang Capital Management 2023 Q1 filed May 15, 2023
- Tang Capital Management 2022 Q4 filed Feb. 14, 2023
- Tang Capital Management 2022 Q3 filed Nov. 14, 2022
- Tang Capital Management 2022 Q2 filed Aug. 15, 2022
- Tang Capital Management 2022 Q1 filed May 16, 2022
- Tang Capital Management 2021 Q4 filed Feb. 14, 2022
- Tang Capital Management 2021 Q3 filed Nov. 15, 2021
- Tang Capital Management 2021 Q2 filed Aug. 16, 2021
- Tang Capital Management 2021 Q1 filed May 17, 2021
- Tang Capital Management 2020 Q4 filed Feb. 16, 2021